• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Kilitch Drugs (India) Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting

    11-02-2026 | 08:05 pm

    Kilitch Drugs' board approved Q3 FY26 consolidated results: Net Sales at ₹53.81 Cr & PAT at ₹4.32 Cr. Board also approved a 1:1 bonus share issue and boosted authorized capital to ₹40 Cr, pending shareholder approval at an upcoming EGM.

    No comments yet. Be the first to comment!

    All announcements from Kilitch Drugs (India) Limited